Patent Assignment
Reel/Frame 018109/0041
Security Agreement
Recorded: 2006-08-15
Pages: 18
Assignor
MEDICURE INTERNATIONAL INC.
Executed: 2006-08-11
Assignee
MERRILL LYNCH CAPITAL CANADA INC.
181 BAY STREET, SUITE 400, TORONTO, ONTARIO, M5J2V8, CANADA
Covered Properties
(45)
Novel Sulfonamide Fibrinogen Receptor Antagonists
Patent:
5,292,756 →
Application:
07/860,747 →
Novel Sulfonamide Fibrinogen Receptor Antagonists
Patent:
5,658,929 →
Application:
08/505,417 →
Compositions for Inhibiting Platelet Aggregation
Patent:
5,733,919 →
Application:
08/735,878 →
Novel Sulfonamide Fibrinogen Receptor Antagonists
Patent:
5,814,643 →
Application:
08/861,545 →
Angioplasty Procedure Using Nonionic Contrast Media
Patent:
5,978,698 →
Application:
08/943,872 →
Compositions for Inhibiting Platelet Aggregation
Patent:
5,972,967 →
Application:
08/965,922 →
Compositions for Inhibiting Platelet Aggregation
Patent:
5,965,581 →
Application:
09/079,776 →
Novel Sulfonamide Fibrinogen Receptor Antagonists
Patent:
5,880,136 →
Application:
09/130,334 →
Novel Sulfonamide Fibrinogen Receptor Antagonists
Patent:
6,040,317 →
Application:
09/221,044 →
Platelet Aggregation Inhibition Using Low Molecular Weight Heparin in Combination with a Gp Iib/Iiia Antagonist
Patent:
6,136,794 →
Application:
09/240,429 →
Treatment of Cardiovascular and Related Pathologies
Patent:
6,677,356 →
Application:
09/645,237 →
Cardioprotective Phosphonates and Malonates
Treatment of Cerebrovascular Disease
Pyridoxine and Pyridoxal Analogues: Cardiovascular Therapeutics
Patent:
6,417,204 →
Application:
09/900,718 →
Pyridoxine and Pyridoxal Analogues: Novel Uses
Patent:
6,548,519 →
Application:
10/147,263 →
Treatment of Cerebrovascular Disease
Cardioprotective Phosphonates and Malonates
Cardioprotective Phosphonates and Malonates
Cardioprotective Phosphonates and Malonates
Cardioprotective Phosphonates and Malonates
Pyridoxine and Pyridoxal Analogues: New Uses
Method for Inhibiting Platelet Aggregation
Heteroaryl phosphonates, compositions containing them and methods of treatment of various disorders using them
Application:
10/549,505 →
Publication:
US 2006/0241083
Treatment of Cardiovascular and Related Pathologies
Treatment of Cardiovascular and Related Pathologies
Treatment of Cardiovascular and Related Pathologies
Treating of Cardiovascular and Related Pathologies
Treatment of Cardiovascular and Related Pathologies
Treatment of Cardiovascular and Related Pathologies
Treatment of cerebrovascular disease
Application:
10/729,276 →
Publication:
US 2004/0121988
Cardioprotective Phosphonates and Malonates
Method for inhibiting platelet aggregation
Application:
10/909,608 →
Publication:
US 2005/0004231
Aryl Sulfonic Pyridoxines as Antiplatelet Agents
Substituted pyridoxines as anti-platelet agents
Application:
10/974,718 →
Publication:
US 2006/0094749
Pyridoxine and Pyridoxal Analogues: New Uses
Combination therapies employing platelet aggregation drugs
Application:
11/177,248 →
Publication:
US 2006/0019929
Combination therapies employing ace inhibitors and uses thereof for the treatment of diabetic disorders
Application:
11/202,272 →
Publication:
US 2006/0035864
Dual Antiplatelet/Anticoagulant Pyridoxine Analogs
Novel formulation of pyridoxal-5'-phosphate and method of preparation
Application:
11/288,971 →
Publication:
US 2007/0243249
Compounds and Methods for Regulating Triglyceride Levels
Combination Therapies Employing Ace Inhibitors and Uses Thereof for the Treatment of Diabetic Disorders
Application:
11/424,069 →
Publication:
US 2007/0060549
Treatment of cardiovascular and related pathologies
Application:
60/740,970 →
Soybean Variety 457114
Application:
60/745,851 →
Treatment of cardiovascular and related pathologies
Application:
60/753,853 →
Treatment of Cardiovascular and Related Pathologies
Application:
60/803,298 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 21, 1997
From: GELOTTE, KARL M.
To: MERCK & CO., INC.
Reel/Frame 008823/0157 →
Assignment of Assignor's Interest
Feb 4, 1999
From: GELOTTE, KARL M.
To: MERCK & CO., INC.
Reel/Frame 009741/0712 →
Assignment of Assignor's Interest
Jul 19, 1999
From: SAX, FREDERIC L.
To: MERCK & CO., INC.
Reel/Frame 010099/0228 →
Assignment of Assignor's Interest
Aug 1, 2000
From: COOK, JACQUELYNN J.; GOULD, ROBERT J.; SAX, FREDERIC L.
To: MERCK & CO., INC.
Reel/Frame 011114/0092 →
Assignment of Assignor's Interest
Dec 11, 2000
From: SETHI, RAJAT; HAQUE, WASIMUL
To: MEDICURE INTERNATIONAL INC.
Reel/Frame 011361/0835 →
Assignment of Assignor's Interest
Jun 25, 2001
From: HAQUE, WASIMUL; SETHI, RAJAT
To: MEDICURE INTERNATIONAL INC.
Reel/Frame 011924/0810 →
Assignment of Assignor's Interest
Jun 25, 2001
From: HAQUE, WASIMUL
To: MEDICURE INTERNATIONAL INC.
Reel/Frame 011924/0987 →
Assignment of Assignor's Interest
Aug 13, 2001
From: HAQUE, WASIMUL
To: MEDICURE INTERNATIONAL INC.
Reel/Frame 012065/0237 →
Assignment of Assignor's Interest
Aug 27, 2002
From: HAQUE, WASIMUL
To: MEDICURE INTERNATIONAL INC.
Reel/Frame 013225/0749 →
Security Interest
Nov 7, 2003
From: ARTERY, LLC
To: PAUL ROYALTY FUND, L.P.; PAUL ROYALTY FUND HOLDINGS II
Reel/Frame 014108/0601 →
Security Interest
Nov 7, 2003
From: GUILFORD PHARMACEUTICALS INC.
To: PAUL ROYALTY FUND, L.P. AND PAUL ROYALTY FUND HOLDINGS II
Reel/Frame 014108/0569 →
Assignment of Assignor's Interest
Nov 7, 2003
From: GUILFORD PHARMACEUTICALS INC.
To: ARTERY LLC
Reel/Frame 014108/0556 →
Assignment of Assignor's Interest
Nov 25, 2003
From: MERCK & CO., INC.
To: ARTERY LLC
Reel/Frame 014146/0902 →
Assignment of Assignor's Interest
Mar 23, 2004
From: MERCK & CO., INC.
To: ARTERY LLC
Reel/Frame 014446/0943 →
Assignment of Assignor's Interest
Dec 6, 2004
From: HAQUE, WASIMUL
To: MEDICURE INTERNATIONAL INC.
Reel/Frame 016042/0762 →
Corrective Assignment to Re-Record Assignment Previously Recorded at Reel 014108 Frame 0556 to Delete U.S. Patent 6,096,075 and U.S Patent 5,719,189 (Inadvertently Listed on Assignment Cover Sheet Filed on November 11, 2003)
Dec 13, 2004
From: GUILFORD PHARMACEUTICALS INC.
To: ARTERY LLC
Reel/Frame 015452/0081 →
Corrective Coversheet to Correct Patent Numbers 6096075 and 5719189 Previously Recorded on Reel 014108, Frame 0569.
Dec 20, 2004
From: GUILFORD PHARMACEUTICALS INC.
To: PAUL ROYALTY FUND, L.P.; PAUL ROYALTY FUND HOLDINGS II
Reel/Frame 015478/0090 →
Corrective Security Interest Assignment to Delete Patent 6,096,075 and 5,719,189.
Dec 22, 2004
From: ARTERY, LLC
To: PAUL ROYALTY FUND, L.P. AND PAUL ROYALTY FUND HOLDINGS II
Reel/Frame 015478/0785 →
Transfer of Grantee's (Debtor's) Rights Under Certain Security Interest Agreements to New Grantee (Secured Party)
Jan 10, 2005
From: PAUL ROYALTY FUND, L.P.
To: ROYALTY FINANCIAL COMPANY LLC
Reel/Frame 015596/0177 →
Transfer of Grantee's (Debtor's) Rights Under Certain Security Interest Agreements to New Grantee (Secured Party).
Jan 12, 2005
From: ROYALTY SECURITIZATION TRUST I
To: DEUTSCHE BANK TRUST COMPANY AMERICAS (AS INDENTURE TRUSTEE)
Reel/Frame 015603/0896 →
Transfer of Grantee's (Debtor's) Rights Under Certain Security Interest Agreements to New Grantee (Secured Party)
Jan 19, 2005
From: ROYALTY FINANCIAL COMPANY LLC
To: ROYALTY SECURITIZATION TRUST I
Reel/Frame 015603/0752 →
Release and Termination of Security Interest Solely in the Collateral Listed in Schedule a (See Document for Details)
Oct 4, 2005
From: PAUL ROYALTY FUND HOLDINGS II
To: ARTERY, LLC; GUILFORD PHARMACEUTICALS, INC.
Reel/Frame 016610/0946 →
Release and Termination of Security Interest Solely in the Collateral Listed in Schedule a (See Document for Details)
Oct 4, 2005
From: DEUTSCHE BANK TRUST COMPANY AMERICAS (AS INDENTURE TRUSTEE)
To: ARTERY, LLC; GUILFORD PHARMACEUTICALS, INC.
Reel/Frame 016610/0964 →
Release and Termination of Security Interest Solely in the Collateral Listed in Schedule a (See Document for Details)
Oct 4, 2005
From: ROYALTY SECURITIZATION TRUST I
To: ARTERY, LLC; GUILFORD PHARMACEUTICALS, INC.
Reel/Frame 016610/0955 →
Change of Name
Aug 3, 2006
From: GUILFORD PHARMACEUTICALS, INC.
To: MGI GP, INC.
Reel/Frame 018047/0247 →